Elucidating gsk-3 substrate and inhibitor binding sites as a tool for inhibitor refinement

被引：0
|
作者：
Licht-murava, A. [1 ]
Plotkin, B. [1 ]
Eisenstein, M. [2 ]
Eldar-Finkelman, H. [1 ]
机构：
[1] Tel Aviv Univ, IL-69978 Tel Aviv, Israel
[2] Weizmann Inst Sci, IL-76100 Rehovot, Israel
来源：
MOLECULAR BIOLOGY OF THE CELL | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
1485
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The structures of human dihydroorotate dehydrogenase with and without inhibitor reveal conformational flexibility in the inhibitor and substrate binding sites
    Walse, Bjorn
    Dufe, Veronica Tamu
    Svensson, Bo
    Fritzson, Ingela
    Dahlberg, Leif
    Khairoullina, Alfia
    Wellmar, Ulf
    Al-Karadaghi, Salam
    BIOCHEMISTRY, 2008, 47 (34) : 8929 - 8936
  • [32] The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor
    Capurro, Valeria
    Lanfranco, Massimiliano
    Summa, Maria
    Porceddu, Pier Francesca
    Ciampoli, Mariasole
    Margaroli, Natasha
    Durando, Lucia
    Garrone, Beatrice
    Ombrato, Rosella
    Tongiani, Serena
    Reggiani, Angelo
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 128
  • [33] Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro
    Selvi Kunnimalaiyaan
    Victoriana K. Schwartz
    Iris Alao Jackson
    T. Clark Gamblin
    Muthusamy Kunnimalaiyaan
    BMC Cancer, 18
  • [34] Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro
    Kunnimalaiyaan, Selvi
    Schwartz, Victoriana K.
    Jackson, Iris Alao
    Gamblin, T. Clark
    Kunnimalaiyaan, Muthusamy
    BMC CANCER, 2018, 18
  • [35] Characterization of a GSK-3 inhibitor in culture of human cord blood primitive hematopoietic cells
    Jiang, Junfen
    Zhao, Mei
    Zhang, Aiying
    Yu, Mingfeng
    Lin, Xiaojuan
    Wu, Mingyuan
    Wang, Xiaonong
    Lu, Huili
    Zhu, Shunying
    Yu, Yan
    Mao, Zhenmin
    Han, Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (07) : 482 - 486
  • [36] GSK-3 inhibitor inhibits cell proliferation and induces apoptosis in human osteosarcoma cells
    Nishimura, Hideki
    Nakamura, Osamu
    Yamagami, Yoshiki
    Mori, Masaki
    Horie, Ryosuke
    Fukuoka, Natsuko
    Yamamoto, Tetsuji
    ONCOLOGY REPORTS, 2016, 35 (04) : 2348 - 2354
  • [37] GSK114: A selective inhibitor for elucidating the biological role of TNNI3K
    Lawhorn, Brian G.
    Philp, Joanne
    Graves, Alan P.
    Shewchuk, Lisa
    Holt, Dennis A.
    Gatto, Gregory J., Jr.
    Kallander, Lara S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (14) : 3355 - 3358
  • [38] Substrate Competitive GSK-3 Inhibitors - strategy and Implications
    Eldar-Finkelman, Hagit
    Licht-Murava, Avital
    Pietrokovski, Shmuel
    Eisenstein, Miriam
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2010, 1804 (03): : 598 - 603
  • [39] The immunostimulatory effect of 9-ING-41, a small molecule GSK-3 inhibitor, in sarcomas
    MacDonald, William J.
    Lew, Samuel
    Huntington, Kelsey E.
    Lulla, Rishi R.
    DeNardo, Bradley D.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2023, 83 (07)
  • [40] NEUROPROTECTION OF GSK-3β INHIBITOR IN TRANSGENIC SOD1-G93A MICE OF ALS
    Ahn, S-W
    Sung, J-J
    Hong, Y-H
    Kim, J-E
    Yang, J-W
    Park, S-Y
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 93 - 93
12345